Imatinib Mesylate or Dasatinib in Treating Patients With Previously Untreated Chronic Phase Chronic Myelogenous Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Takeda
Novartis
Hackensack Meridian Health
St. Jude Children's Research Hospital
Gamida Cell ltd
Dartmouth-Hitchcock Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
Novartis
Thomas Jefferson University
Baylor College of Medicine
Novartis
Novartis
OHSU Knight Cancer Institute
Stanford University
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
American Regent, Inc.
Masonic Cancer Center, University of Minnesota
Thomas Jefferson University
M.D. Anderson Cancer Center
Novartis
Memorial Sloan Kettering Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Stanford University
Kyowa Kirin Co., Ltd.
Northwestern University
Novartis
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
Pfizer
University of Nebraska
M.D. Anderson Cancer Center
University of Nebraska
Center for International Blood and Marrow Transplant Research
Stanford University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Northside Hospital, Inc.
Fred Hutchinson Cancer Center
Fate Therapeutics
Karyopharm Therapeutics Inc